Allergan plc (NYSE:AGN) spotted trading -3.30% off 52-week high price. On the other end, the stock has been noted 64.69% away from the low price over the last 52-weeks. The stock changed -1.26% to recent value of $188.19. The stock transacted 3445143 shares during most recent day however it has an average volume of 2.30M shares. The company has 328.31M of outstanding shares and 327.36M shares were floated in the market.
On Jan. 24, 2020, Allergan plc (NYSE:AGN) reported that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the first quarter of 2020. The dividend will be paid on March 13, 2020 to shareholders of record at the close of business on February 14, 2020.
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.
Its earnings per share (EPS) expected to touch remained 24.90% for this year while earning per share for the next 5-years is expected to reach at 3.40%. AGN has a gross margin of 85.00% and an operating margin of -60.30% while its profit margin remained -58.50% for the last 12 months.
According to the most recent quarter its current ratio was 1 that represents company’s ability to meet its current financial obligations. The price moved ahead of -1.89% from the mean of 20 days, -0.07% from mean of 50 days SMA and performed 15.15% from mean of 200 days price. Company’s performance for the week was -2.91%, -1.74% for month and YTD performance remained -1.56%.
Nathaniel worked as a reporter for an online news publication in China for two years, covering general city news; he also used to work for an international travel agency before pursuing a career in journalism. In his free time, Nathaniel enjoys outdoor recreation, following sports of all kinds. Nathaniel Schultz reports about Business category. Before joining Marketsnip.com, he worked as a news reporter for other publications, covering technology and health reporting. He earned his Master’s at School of Journalism, where he worked as a news reporter besides learning pertinent skills in magazine editing and interactive production.
He can be reached email at [email protected]
ADDRESS # 1454 West Wylie Street, Bloomington, IN 47403 USA
CONTACT # 423-808-5425
